Retention and migration of a specially designed alprostadil transdermal cream was assessed after single-dose administration to the glans meatus of the penis. Seven men were enrolled in this two-way ...

Oct. 20, 2005 (Montreal) — A transdermal cream formulation of alprostadil may be an effective treatment for female sexual arousal disorder (FSAD), according to phase 2 research. Alprostadil is a ...

May 25, 2012 (Atlanta, Georgia) — A new formulation of alprostadil cream 0.4% (Femprox, Apricus Biosciences Inc), administered topically, significantly improved symptoms of female sexual arousal ...

NICE has not published a clinical guideline on erectile dysfunction (ED). The European Association of Urology 2014 guidelines on male sexual dysfunction define ED as the persistent inability to attain ...

In 2 randomised controlled trials (RCTs) alprostadil 300 microgram cream statistically significantly improved erectile function and intercourse ability compared with placebo but the average absolute ...

The FDA has not approved any medicated creams for treating ED, and has issued warnings about products making such claims. Vitaros, a cream containing alprostadil, is approved in Canada and Europe but ...

Overview: Alprostadil is used to diagnose and treat erectile dysfunction (ED). The most common side effect with alprostadil is penis pain. Serious side effects are rare but can include an unwanted ...

Ferring Pharmaceuticals purchased ex-U.S. assets and rights to Apricus Biosciences’ on-demand topical erectile dysfunction therapy cream Vitaros ® (alprostadil) for potentially $12.7 million. Ferring ...

As partner Mylan NV makes ready to launch in Canada the erectile dysfunction (ED) drug-device combo Vitaros (alprostadil cream) – approved there as well as certain countries in Europe, Latin America ...